We are live on ! Find out more
ECP

Empyrean Capital Partners Portfolio holdings

AUM $3.03B
1-Year Est. Return 47.81%
This Fund
S&P 500
This Quarter Est. Return
-8.63%
1 Year Est. Return
+47.81%
3 Year Est. Return
+131.37%
5 Year Est. Return
+161.39%
10 Year Est. Return
+590.42%
AUM
$2.03B
AUM Growth
-$109M
Cap. Flow
-$895M
Cap. Flow %
-44.01%
Top 10 Hldgs %
55.14%
Holding
76
New
17
Increased
7
Reduced
13
Closed
23

Sector Composition

Rank Sector Weight
1 Miscellaneous 56.05%
2 Communication Services 10.23%
3 Financials 9.07%
4 Healthcare 8.27%
5 Technology 6.97%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SPY icon
1
CALL
State Street SPDR S&P 500 ETF Trust
SPY
$799B
$326M 16.02%
+1,700,000
New +$345M
FXE icon
2
PUT
Invesco CurrencyShares Euro Currency Trust
FXE
$357M
$141M 6.95%
+1,288,800
New +$141M
TLT icon
3
CALL
iShares 20+ Year Treasury Bond ETF
TLT
$46.4B
$117M 5.76%
+947,300
New +$115M
ISBC
4
DELISTED
Investors Bancorp, Inc.
ISBC
$111M 5.46%
8,989,604
-10,396
-0.1% -$126K
CMCSA icon
5
Comcast
CMCSA
$86.7B
$98.1M 4.83%
3,450,000
+650,000
+23% +$19.3M
PFE icon
6
Pfizer
PFE
$157B
$69.9M 3.44%
2,344,096
+657,696
+39% +$21.1M
THS
7
CALL
DELISTED
Treehouse Foods
THS
$66.1M 3.25%
+850,000
New +$68.1M
TFSL icon
8
TFS Financial
TFSL
$4.79B
$64.6M 3.18%
3,745,000
-1,255,000
-25% -$21.3M
ARMK icon
9
Aramark
ARMK
$15.4B
$64.4M 3.17%
3,008,640
-185,309
-6% -$4.23M
LTRPA
10
DELISTED
Liberty TripAdvisor Holdings, Inc. Series A
LTRPA
$63.1M 3.1%
2,845,032
-53,420
-2% -$1.48M
PFE icon
11
CALL
Pfizer
PFE
$157B
$62.8M 3.09%
+2,108,000
New +$67.6M
AMAT icon
12
Applied Materials
AMAT
$334B
$59.5M 2.93%
4,050,000
-1,200,000
-23% -$20.1M
WMB icon
13
CALL
Williams Companies
WMB
$87.6B
$55.3M 2.72%
+1,500,000
New +$74.7M
IWM icon
14
CALL
iShares Russell 2000 ETF
IWM
$76.9B
$54.6M 2.69%
+500,000
New +$59.3M
ABBV icon
15
AbbVie
ABBV
$465B
$49M 2.41%
+900,000
New +$58.6M
CAT icon
16
PUT
Caterpillar
CAT
$360B
$47.7M 2.35%
+730,000
New +$55.8M
AER icon
17
AerCap
AER
$21.7B
$44.7M 2.2%
1,168,000
+268,000
+30% +$11.8M
FWONK icon
18
Liberty Media Series C
FWONK
$23.8B
$34.7M 1.71%
1,422,428
+56,511
+4% +$1.45M
TAP icon
19
Molson Coors Class B
TAP
$7.32B
$32.1M 1.58%
387,038
-212,962
-35% -$15.4M
SFS
20
DELISTED
Smart & Final Stores, Inc.
SFS
$31.3M 1.54%
1,989,649
-300,462
-13% -$5.01M
TMUS icon
21
T-Mobile US
TMUS
$194B
$30.3M 1.49%
761,000
-499,000
-40% -$19.9M
AGN
22
DELISTED
Allergan plc
AGN
$29.6M 1.46%
109,000
-336,753
-76% -$103M
NIHD
23
DELISTED
NII Holdings, Inc. Common Stock
NIHD
$26.1M 1.28%
+4,007,912
New +$43.8M
INVA icon
24
Innoviva
INVA
$1.51B
$19.7M 0.97%
2,742,302
+629,410
+30% +$8.55M
FWONA icon
25
Liberty Media Series A
FWONA
$21.8B
$18.9M 0.93%
785,300
+59,493
+8% +$1.48M

Similar funds

Empyrean Capital Partners's Q3 2015 Portfolio in Review

As of Q3 2015, Empyrean Capital Partners held 76 positions worth $2.03B, down 5.1% from $2.14B the previous quarter. Its ten largest holdings account for 55% of the portfolio.

Empyrean Capital Partners withdrew a net $895M in Q3 2015, closing 23 positions and reducing 13 holdings. Its most notable exit was DIRECTV COM STK (DE), an estimated $149M position sold in full.

By sector, the portfolio is most concentrated in Miscellaneous at 56% of assets, up from 25% a quarter earlier, followed by Communication Services and Financials.

Against the trend, Empyrean Capital Partners opened a new position in AbbVie worth $49M.

  • Empyrean Capital Partners's largest Q3 2015 buy was AbbVie: 900,000 shares worth $49M.
  • Empyrean Capital Partners added most to Pfizer in Q3 2015, an estimated $21.1M increase.
  • Empyrean Capital Partners's biggest Q3 2015 reduction was Allergan plc, cutting an estimated $103M.
  • Empyrean Capital Partners fully exited DIRECTV COM STK (DE) in Q3 2015, selling an estimated $149M.
  • Empyrean Capital Partners's ten largest holdings make up 55% of its $2.03B portfolio in Q3 2015.
  • Empyrean Capital Partners opened 17 new positions and closed 23 in Q3 2015.
  • Empyrean Capital Partners's portfolio value fell 5.1% quarter-over-quarter to $2.03B.

Based on Empyrean Capital Partners's 13F filing for Q3 2015, filed 16 Nov 2015.